Clinical usefulness of cell-based indirect immunofluorescence assay for the detection of aquaporin-4 antibodies in neuromyelitis optica spectrum disorder.

PubWeight™: 0.78‹?›

🔗 View Article (PMC 3427820)

Published in Ann Lab Med on August 13, 2012

Authors

Eun-suk Kang1, Ju-Hong Min, Kwang Ho Lee, Byoung Joon Kim

Author Affiliations

1: Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

Articles cited by this

Revised diagnostic criteria for neuromyelitis optica. Neurology (2006) 17.57

A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet (2004) 13.18

The spectrum of neuromyelitis optica. Lancet Neurol (2007) 11.83

IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med (2005) 10.39

The clinical course of neuromyelitis optica (Devic's syndrome). Neurology (1999) 8.03

A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain (2002) 6.85

Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre. Brain (2007) 4.82

Neuromyelitis optica and non organ-specific autoimmunity. Arch Neurol (2008) 3.95

AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance. Nat Rev Neurol (2010) 3.28

An open label study of the effects of rituximab in neuromyelitis optica. Neurology (2005) 2.99

Antibody to aquaporin-4 in the long-term course of neuromyelitis optica. Brain (2008) 2.96

Implications of the aquaporin-4 structure on array formation and cell adhesion. J Mol Biol (2005) 2.50

Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis. Arch Neurol (2008) 2.48

Plasma exchange for severe attacks of CNS demyelination: predictors of response. Neurology (2002) 2.41

Multiple sclerosis in the Japanese population. Lancet Neurol (2003) 2.15

Standardized method for the detection of antibodies to aquaporin-4 based on a highly sensitive immunofluorescence assay employing recombinant target antigen. J Neurol Sci (2010) 1.75

Diagnosis of neuromyelitis spectrum disorders: comparative sensitivities and specificities of immunohistochemical and immunoprecipitation assays. Arch Neurol (2009) 1.61

Detection of anti-aquaporin-4 antibodies in neuromyelitis optica: current status of the assays. Int MS J (2008) 1.61

Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica. PLoS Med (2007) 1.61

Brain abnormalities in Sjogren syndrome with recurrent CNS manifestations: association with neuromyelitis optica. Mult Scler (2009) 1.58

Prediction of neuromyelitis optica attack severity by quantitation of complement-mediated injury to aquaporin-4-expressing cells. Arch Neurol (2009) 1.55

Neuromyelitis optica and anti-aquaporin-4 antibodies measured by an enzyme-linked immunosorbent assay. J Neuroimmunol (2008) 1.51

Establishment of a new sensitive assay for anti-human aquaporin-4 antibody in neuromyelitis optica. Tohoku J Exp Med (2006) 1.46

Immunosuppressive therapy is more effective than interferon in neuromyelitis optica. Mult Scler (2007) 1.45

Neurological autoimmunity targeting aquaporin-4. Neuroscience (2009) 1.39

Devic's neuromyelitis optica: clinical, laboratory, MRI and outcome profile. J Neurol Sci (2002) 1.33

Strategy for anti-aquaporin-4 auto-antibody identification and quantification using a new cell-based assay. Clin Immunol (2010) 1.20

Frequency and syndrome specificity of antibodies to aquaporin-4 in neurological patients with rheumatic disorders. Mult Scler (2011) 1.19

Antiacquaporin 4 antibodies detection by different techniques in neuromyelitis optica patients. Mult Scler (2009) 1.13

Aquaporin-4 autoimmune syndrome and anti-aquaporin-4 antibody-negative opticospinal multiple sclerosis in Japanese. Mult Scler (2009) 0.96

Articles by these authors

Collateral flow predicts response to endovascular therapy for acute ischemic stroke. Stroke (2011) 2.80

Repetitive transcranial magnetic stimulation-induced corticomotor excitability and associated motor skill acquisition in chronic stroke. Stroke (2006) 2.63

Metabolic engineering of Escherichia coli for the production of L-valine based on transcriptome analysis and in silico gene knockout simulation. Proc Natl Acad Sci U S A (2007) 2.43

Development of extensive brain lesions following fingolimod (FTY720) treatment in a patient with neuromyelitis optica spectrum disorder. Mult Scler (2011) 2.30

Coagulopathy and embolic signal in cancer patients with ischemic stroke. Ann Neurol (2010) 2.11

Collateral flow averts hemorrhagic transformation after endovascular therapy for acute ischemic stroke. Stroke (2011) 1.67

Ischemic stroke in cancer patients with and without conventional mechanisms: a multicenter study in Korea. Stroke (2010) 1.53

Gold nanoparticles attenuate LPS-induced NO production through the inhibition of NF-kappaB and IFN-beta/STAT1 pathways in RAW264.7 cells. Nitric Oxide (2010) 1.50

Improved outcome after atherosclerotic stroke in male smoker. J Neurol Sci (2007) 1.48

Statistical MUNE: a comparison of two methods of setting recording windows in healthy subjects and ALS patients. Clin Neurophysiol (2007) 1.43

Digitally tunable physicochemical coding of material composition and topography in continuous microfibres. Nat Mater (2011) 1.38

A computerized in-hospital alert system for thrombolysis in acute stroke. Stroke (2010) 1.35

Metabolite essentiality elucidates robustness of Escherichia coli metabolism. Proc Natl Acad Sci U S A (2007) 1.26

Enhancing the working memory of stroke patients using tDCS. Am J Phys Med Rehabil (2009) 1.22

Learning curves for colonoscopy: a prospective evaluation of gastroenterology fellows at a single center. Gut Liver (2010) 1.22

MR mismatch profiles in patients with intracranial atherosclerotic stroke: a comprehensive approach comparing stroke subtypes. J Cereb Blood Flow Metab (2009) 1.20

Association of thyroid autoantibodies with moyamoya-type cerebrovascular disease: a prospective study. Stroke (2009) 1.20

Ischemic stroke and cancer: stroke severely impacts cancer patients, while cancer increases the number of strokes. J Clin Neurol (2011) 1.18

Prediction of hemorrhagic transformation in acute ischemic stroke: role of diffusion-weighted imaging and early parenchymal enhancement. AJNR Am J Neuroradiol (2005) 1.14

Isolated tongue tremor after removal of cerebellar pilocytic astrocytoma: Functional analysis with SPECT study. Mov Disord (2007) 1.12

Impact of baseline tissue status (diffusion-weighted imaging lesion) versus perfusion status (severity of hypoperfusion) on hemorrhagic transformation. Stroke (2010) 1.08

Frequency analysis and clinical characterization of spinocerebellar ataxia types 1, 2, 3, 6, and 7 in Korean patients. Arch Neurol (2003) 1.06

Mutation analysis of SPG4 and SPG3A genes and its implication in molecular diagnosis of Korean patients with hereditary spastic paraplegia. Arch Neurol (2005) 1.00

The usefulness of brain MRI at onset in the differentiation of multiple sclerosis and seropositive neuromyelitis optica spectrum disorders. Mult Scler (2013) 0.98

A novel magnetic resonance imaging approach to collateral flow imaging in ischemic stroke. Ann Neurol (2014) 0.97

Development of a markerless gene knock-out system for Mannheimia succiniciproducens using a temperature-sensitive plasmid. FEMS Microbiol Lett (2007) 0.97

Prevalence and risk factors of intracranial atherosclerosis in an asymptomatic korean population. J Clin Neurol (2006) 0.96

Combined extracranial and intracranial atherosclerosis in Korean patients. Arch Neurol (2003) 0.96

Prognosis of ocular myasthenia in Korea: a retrospective multicenter analysis of 202 patients. J Neurol Sci (2008) 0.95

Subcortical aphasia after striatocapsular infarction: quantitative analysis of brain perfusion SPECT using statistical parametric mapping and a statistical probabilistic anatomic map. J Nucl Med (2007) 0.95

Novel PDMS cylindrical channels that generate coaxial flow, and application to fabrication of microfibers and particles. Lab Chip (2010) 0.94

Cerebral ischemia detected with diffusion-weighted MR imaging after protected carotid artery stenting: comparison of distal balloon and filter device. Korean J Radiol (2007) 0.94

Anethum graveloens flower extracts inhibited a lipopolysaccharide-induced inflammatory response by blocking iNOS expression and NF-κB activity in macrophages. Biosci Biotechnol Biochem (2012) 0.92

Characteristics of patients with target magnetic resonance mismatch profile: data from two geographically and racially distinct populations. Cerebrovasc Dis (2009) 0.91

Neurologic outcomes of thymectomy in myasthenia gravis: comparative analysis of the effect of thymoma. J Thorac Cardiovasc Surg (2007) 0.91

Multiphasic perfusion computed tomography in hyperacute ischemic stroke: comparison with diffusion and perfusion magnetic resonance imaging. J Comput Assist Tomogr (2003) 0.90

CT sign of brain swelling without concomitant parenchymal hypoattenuation: comparison with diffusion- and perfusion-weighted MR imaging. Radiology (2005) 0.90

Anti-inflammatory effects of 8-hydroxydeoxyguanosine in LPS-induced microglia activation: suppression of STAT3-mediated intercellular adhesion molecule-1 expression. Exp Mol Med (2006) 0.90

In planta differential targeting analysis of Thermotoga maritima Cel5A and CBM6-engineered Cel5A for autohydrolysis. Transgenic Res (2010) 0.89

Hepatocellular carcinoma in older adults: clinical features, treatments, and survival. J Am Geriatr Soc (2011) 0.89

Perfusion-weighted MRI as a predictor of clinical outcomes following medullary infarctions. Cerebrovasc Dis (2010) 0.88

Microfluidic wet spinning of chitosan-alginate microfibers and encapsulation of HepG2 cells in fibers. Biomicrofluidics (2011) 0.88

Novel mutation in the HSN2 gene in a Korean patient with hereditary sensory and autonomic neuropathy type 2. J Hum Genet (2006) 0.87

Topographic location of acute pontine infarction is associated with the development of progressive motor deficits. Stroke (2012) 0.86

Stunned brain syndrome: serial diffusion perfusion MRI of delayed recovery following revascularisation for acute ischaemic stroke. J Neurol Neurosurg Psychiatry (2010) 0.86

Clinical MRI cutoff points for predicting lacunar stroke may not exist: need for a grading rather than a dichotomizing system. Cerebrovasc Dis (2007) 0.86

Antioxidative iridoid glycosides and phenolic compounds from Veronica peregrina. Arch Pharm Res (2009) 0.85

Comparison of diabetic neuropathy symptom score and medial plantar sensory nerve conduction studies in diabetic patients showing normal routine nerve conduction studies. Intern Med (2008) 0.85

Anti-tumor metastatic activity of beta-glucan purified from mutated Saccharomyces cerevisiae. Int Immunopharmacol (2007) 0.84

Reversible verbal and visual memory deficits after left retrosplenial infarction. J Clin Neurol (2007) 0.84

Differential pathophysiological mechanisms of stroke evolution between new lesions and lesion growth: perfusion-weighted imaging study. Cerebrovasc Dis (2010) 0.84

Fed-batch culture of Escherichia coli for L-valine production based on in silico flux response analysis. Biotechnol Bioeng (2010) 0.84

Spectrum of NOTCH3 mutations in Korean patients with clinically suspicious cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Neurobiol Aging (2013) 0.84

Protective effects of Gastrodia elata Blume on MPP+-induced cytotoxicity in human dopaminergic SH-SY5Y cells. J Ethnopharmacol (2010) 0.84

Clinical and radiological outcomes after intracranial atherosclerotic stroke: a comprehensive approach comparing stroke subtypes. Cerebrovasc Dis (2011) 0.83

Ischemic stroke in Takayasu's arteritis: lesion patterns and possible mechanisms. J Clin Neurol (2012) 0.83

Malignant middle cerebral artery infarction in hyperacute ischemic stroke: evaluation with multiphasic perfusion computed tomography maps. J Comput Assist Tomogr (2004) 0.82

Indole-3-carbinol inhibits LPS-induced inflammatory response by blocking TRIF-dependent signaling pathway in macrophages. Food Chem Toxicol (2013) 0.82

Early detection of cardiac involvement in Miyoshi myopathy: 2D strain echocardiography and late gadolinium enhancement cardiovascular magnetic resonance. J Cardiovasc Magn Reson (2010) 0.82

Biomarkers of asymptomatic carotid stenosis in patients undergoing coronary artery bypass grafting. Stroke (2011) 0.82

Anti-tumor immunostimulatory effect of heat-killed tumor cells. Exp Mol Med (2008) 0.82

Differential risk factors for lacunar stroke depending on the MRI (white and red) subtypes of microangiopathy. PLoS One (2012) 0.81

Sulcal effacement on fluid attenuation inversion recovery magnetic resonance imaging in hyperacute stroke: association with collateral flow and clinical outcomes. Stroke (2011) 0.81

Subclinical diabetic neuropathy with normal conventional electrophysiological study. J Neurol (2007) 0.81

Clinical predictors of steroid-induced exacerbation in myasthenia gravis. J Clin Neurosci (2006) 0.81

Role of statin in atrial fibrillation-related stroke: an angiographic study for collateral flow. Cerebrovasc Dis (2014) 0.81

Chrysanthemum morifolium Ramat (CM) extract protects human neuroblastoma SH-SY5Y cells against MPP+-induced cytotoxicity. J Ethnopharmacol (2009) 0.81

Multiphasic perfusion CT in acute middle cerebral artery ischemic stroke: prediction of final infarct volume and correlation with clinical outcome. Korean J Radiol (2002) 0.81

Multiphasic perfusion computed tomography as a predictor of collateral flow in acute ischemic stroke: comparison with digital subtraction angiography. Eur Neurol (2012) 0.80

Microembolic signals in acute posterior circulation cerebral ischemia: sources and consequences. Stroke (2012) 0.80

Prolonged Corrected QT Interval in Patients with Myotonic Dystrophy Type 1. J Clin Neurol (2013) 0.80

Effect of eriodictyol on the development of atopic dermatitis-like lesions in ICR mice. Biol Pharm Bull (2013) 0.80

Large-artery stenosis predicts subsequent vascular events in patients with transient ischemic attack. J Clin Neurol (2007) 0.80

Cardiac dysrhythmias,cardiomyopathy and muscular dystrophy in patients with Emery-Dreifuss muscular dystrophy and limb-girdle muscular dystrophy type 1B. J Korean Med Sci (2005) 0.80

Effects of swimming exercise and soybean supplementation on the immune functions of rats fed a high-fat diet. Clin Exp Pharmacol Physiol (2007) 0.80

Thyroid storm during induction of anesthesia. Korean J Anesthesiol (2012) 0.80

Rational design of Escherichia coli for L-isoleucine production. ACS Synth Biol (2012) 0.79

Atypical hereditary sensory and autonomic neuropathy type IV with neither mental retardation nor pain insensitivity. J Child Neurol (2012) 0.79

Prediction of progressive motor deficits in patients with deep subcortical infarction. Cerebrovasc Dis (2008) 0.79

The minor spliceosomal protein U11/U12-31K is an RNA chaperone crucial for U12 intron splicing and the development of dicot and monocot plants. PLoS One (2012) 0.79

Clinical presentation and ischemic zone on MRI in cancer patients with acute ischemic stroke. Eur Neurol (2012) 0.79

Microfluidic fabrication of cell adhesive chitosan microtubes. Biomed Microdevices (2013) 0.79

Age-distinct predictors of symptomatic cervicocephalic atherosclerosis. Cerebrovasc Dis (2008) 0.78

One-stage reconstruction for midfacial defect after radical tumor resection. Clin Exp Otorhinolaryngol (2011) 0.78

Bilateral basal ganglia lesions of primary Sjogren syndrome presenting with generalized chorea. Parkinsonism Relat Disord (2008) 0.78

Sauchinone attenuates oxidative stress-induced skeletal muscle myoblast damage through the down-regulation of ceramide. Biol Pharm Bull (2011) 0.78

Multiphasic helical computed tomography predicts subsequent development of severe brain edema in acute ischemic stroke. Arch Neurol (2004) 0.78

The effects of β-glucans on cancer metastasis. Anticancer Agents Med Chem (2013) 0.78

The determinants of stroke phenotypes were different from the predictors (CHADS2 and CHA2DS2-VASc) of stroke in patients with atrial fibrillation: a comprehensive approach. BMC Neurol (2011) 0.78

Symptomatic brain involvement as the initial manifestation of neuromyelitis optica. J Clin Neurosci (2013) 0.77

A Case Report of Reiter's Syndrome with Progressive Myelopathy. J Clin Neurol (2007) 0.77

Bortezomib, melphalan, and prednisolone combination chemotherapy for newly diagnosed light chain (AL) amyloidosis. Amyloid (2014) 0.77

Heterologous expression of endo-1,4-β-xylanase A from Schizophyllum commune in Pichia pastoris and functional characterization of the recombinant enzyme. Enzyme Microb Technol (2013) 0.77

Purification and characterization of a nitric oxide inhibitory peptide from Ruditapes philippinarum. Food Chem Toxicol (2012) 0.77

Motor-intentional disorders in right hemisphere stroke. Cogn Behav Neurol (2009) 0.76

Autologous stem cell transplantation in light-chain amyloidosis patients: a single-center experience in Korea. Amyloid (2013) 0.76